Segarra-Casas A, Yepez V, Demidov G, Laurie S, Esteve-Codina A, Gagneur J
Int J Mol Sci. 2024; 25(14).
PMID: 39063034
PMC: 11276803.
DOI: 10.3390/ijms25147793.
Dori A, Scutifero M, Passamano L, Zoppi D, Ruggiero L, Trabacca A
Acta Myol. 2024; 43(1):8-15.
PMID: 38586166
PMC: 10997039.
DOI: 10.36185/2532-1900-398.
Okamoto K, Matsunari H, Nakano K, Umeyama K, Hasegawa K, Uchikura A
Regen Ther. 2023; 24:451-458.
PMID: 37772130
PMC: 10523442.
DOI: 10.1016/j.reth.2023.09.010.
Viggiano E, Picillo E, Passamano L, Onore M, Piluso G, Scutifero M
Genes (Basel). 2023; 14(1).
PMID: 36672955
PMC: 9859256.
DOI: 10.3390/genes14010214.
Dori A, Guglieri M, Scutifero M, Passamano L, Trabacca A, Politano L
Acta Myol. 2022; 40(4):152-157.
PMID: 35047755
PMC: 8744011.
DOI: 10.36185/2532-1900-058.
Quantitative Muscle MRI and Clinical Findings in Women With Pathogenic Dystrophin Gene Variants.
Fornander F, Solheim T, Eisum A, Poulsen N, Andersen A, Dahlqvist J
Front Neurol. 2021; 12:707837.
PMID: 34539555
PMC: 8446520.
DOI: 10.3389/fneur.2021.707837.
Impact of estrogen deficiency on diaphragm and leg muscle contractile function in female mdx mice.
Vang P, Baumann C, Barok R, Larson A, Dougherty B, Lowe D
PLoS One. 2021; 16(3):e0249472.
PMID: 33788896
PMC: 8011782.
DOI: 10.1371/journal.pone.0249472.
Parent Project Muscular Dystrophy Females with Dystrophinopathy Conference, Orlando, Florida June 26 - June 27, 2019.
Apkon S, Kinnett K, Cripe L, Duan D, Jackson J, Kornegay J
J Neuromuscul Dis. 2020; 8(2):315-322.
PMID: 33361607
PMC: 10497321.
DOI: 10.3233/JND-200555.
cerebellar circuit function is disrupted in an mouse model of Duchenne muscular dystrophy.
Stay T, Miterko L, Arancillo M, Lin T, Sillitoe R
Dis Model Mech. 2019; 13(2).
PMID: 31704708
PMC: 6906634.
DOI: 10.1242/dmm.040840.
Molecular Genetics Analysis of 70 Chinese Families With Muscular Dystrophy Using Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing.
Wang D, Gao M, Zhang K, Jin R, Lv Y, Liu Y
Front Pharmacol. 2019; 10:814.
PMID: 31404137
PMC: 6669794.
DOI: 10.3389/fphar.2019.00814.
A Mutation in Dystrophin Causing Muscular Dystrophy in a Female Patient.
Yu H, Chen Y, Liu G, Wu Z
Chin Med J (Engl). 2017; 130(19):2273-2278.
PMID: 28937030
PMC: 5634074.
DOI: 10.4103/0366-6999.215338.
Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status.
Miyagoe-Suzuki Y, Nishiyama T, Nakamura M, Narita A, Takemura F, Masuda S
Stem Cells Int. 2017; 2017:7906843.
PMID: 28491099
PMC: 5405591.
DOI: 10.1155/2017/7906843.
Clinical and Genetic Characterization of Female Dystrophinopathy.
Lee S, Lee J, Lee K, Choi Y
J Clin Neurol. 2015; 11(3):248-51.
PMID: 26022459
PMC: 4507379.
DOI: 10.3988/jcn.2015.11.3.248.
Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model.
Brinkmeyer-Langford C, Kornegay J
Curr Genomics. 2014; 14(5):330-42.
PMID: 24403852
PMC: 3763684.
DOI: 10.2174/13892029113149990004.
Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy.
Juan-Mateu J, Rodriguez M, Nascimento A, Jimenez-Mallebrera C, Gonzalez-Quereda L, Rivas E
Orphanet J Rare Dis. 2012; 7:82.
PMID: 23092449
PMC: 3492175.
DOI: 10.1186/1750-1172-7-82.
MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy.
Forbes S, Lott D, Finkel R, Senesac C, Byrne B, Sweeney H
Neuromuscul Disord. 2012; 22 Suppl 2:S111-21.
PMID: 22980762
PMC: 3458312.
DOI: 10.1016/j.nmd.2012.05.013.
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype.
Brioschi S, Gualandi F, Scotton C, Armaroli A, Bovolenta M, Falzarano M
BMC Med Genet. 2012; 13:73.
PMID: 22894145
PMC: 3459813.
DOI: 10.1186/1471-2350-13-73.
Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis.
Yoon J, Kim S, Ki C, Kwon M, Lim M, Kwon S
J Korean Med Sci. 2011; 26(4):587-91.
PMID: 21468271
PMC: 3069583.
DOI: 10.3346/jkms.2011.26.4.587.
Clinical and genetic characterization of manifesting carriers of DMD mutations.
Soltanzadeh P, Friez M, Dunn D, von Niederhausern A, Gurvich O, Swoboda K
Neuromuscul Disord. 2010; 20(8):499-504.
PMID: 20630757
PMC: 2944769.
DOI: 10.1016/j.nmd.2010.05.010.
Manifesting carriage of a Duchenne muscular dystrophy mutation: an unusual cause of impaired lung function in CF.
Walker W, Connett G
J R Soc Med. 2010; 103 Suppl 1:S27-9.
PMID: 20573666
PMC: 2905027.
DOI: 10.1258/jrsm.2010.s11007.